COVID Testing Kit Market to grow at a CAGR of 7.31% during 2025 to 2035; Driven by Continued Demand for Rapid Infectious Disease Detection and Increasing Adoption of At-Home Testing and Point-of-Care Diagnostic Solutions

COVID Testing Kit Market Highlights

The COVID Testing Kit Market was estimated at 81.0 USD Billion in 2024. The COVID Testing Kit industry is projected to grow from 86.92 USD Billion in 2025 to 176.04 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.31% during the forecast period 2025 - 2035. Due to such increasing numbers of cases, there is a growing demand for more COVID-19 testing kits and devices, hence driving the market growth.

Key Players

MRFR recognizes the following companies as the Key Players in the Global COVID Testing Kit— Abbott (US), BioMérieux SA (France), Bio-Rad Laboratories, Inc. (US), Chembio Diagnostic Systems, Inc. (US), Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), GenMark (US), Henry Schein, Inc. (US), Thermo Fisher Scientific Inc. (US), Qiagen (Germany), Siemens AG (Germany), Guangzhou Wondfo Biotech (China), Robert Bosch GmbH (Germany), Cellex (US), Mayo Clinic Laboratories (US), Mount Sinai Laboratory (US), Zhejiang Orient Gene Biotech Co., Ltd. (China), Dynamiker Biotechnology (Tianjin) Co., Ltd (China), Biomedomics Inc. (US), Safecare Biotech (Hangzhou) Co., Ltd (China), Ortho Clinical Diagnostics (US), Innovita Biological Technology Co., Ltd (China), Guangdong Hecin Scientific, Inc. (China), Advaite, Inc. (US), Mylab Discovery Solutions Pvt. Ltd (India), BGI Group (China), and others.

Segment Analysis

Global COVID Testing Kit is segmented based on type and application. The global COVID testing kit market, by type, has been segmented into rapid test kit, RT-PCR, and others. The global COVID testing kit market, by application, has been segmented into hospitals, clinics, and others. The hospital segment accounted for the largest market share owing to the high adoption of advanced diagnostic technologies among healthcare professionals.

Regional Analysis

Global COVID Testing Kit Market, based on region, has been divided into Europe, the Americas, Asia-Pacific, and Middle East & Africa.

The European market for the COVID testing kit market, by country, been divided into Russia, Germany, Spain, Italy, the UK, France, and the Rest of Europe. Europe accounted for the largest market share in the global COVID testing kit market

The Americas COVID testing kit market has been divided, by country, into North America and Latin America. The North American COVID testing kit market has been further divided into the US and Canada, whereas the Latin American COVID testing kit market is sub-segmented into Brazil, Argentina, Mexico, Colombia, and the rest of Latin America.

Regulatory bodies such as the Food and Drugs Administration (FDA) have given emergency use authorizations (EUA) for various diagnostics kits and devices to manage the shortage of diagnostic devices. For instance, in March 2020, the US FDA issued a EUA for a molecular point of care test kit by Abbott for the rapid detection of COVID-19.

The Asia-Pacific market for the COVID testing kit market has been further divided into India, Australia, South Korea, Japan, China, Malaysia, Thailand, Vietnam, Indonesia, Philippines, Taiwan, and Rest of Asia-Pacific.

The Middle East & Africa COVID testing kit market has been bifurcated into the Middle East and Africa. The Middle Eastern market for the COVID testing kit has been further divided into Turkey, the United Arab Emirates, Saudi Arabia, and the Rest of the Middle East. Rising cases in the UAE, Saudi Arabia, and other countries are set to push the demand for diagnostic kits. For instance, as on 8th June 2020, the total cases in Saudi Arabia were 105,283.

Key Findings of the Study

• North America remains the largest market for COVID testing kits, reflecting robust healthcare infrastructure and regulatory support.


• Asia-Pacific is identified as the fastest-growing region, driven by increasing healthcare investments and rising consumer awareness.


• RT-PCR assay kits continue to dominate the market, while immunoassay test strips are emerging as the fastest-growing segment.


• Technological advancements and regulatory support are key drivers, alongside the ongoing need for testing due to emerging variants.